Freya Biosciences: Valuation, Funding & Investors
Freya Biosciences is a transatlantic biotechnology company focused on advancing women's health. The company is dedicated to identifying and developing microbial immunotherapies through its DYSCOVER™ platform, targeting conditions such as bacterial vaginosis and aiming to prevent pre-term birth.
Leadership & Board
- Current Number of Employees
- 27
- Current LinkedIn Followers
- 5,323
Latest Estimated Valuation
- Total Amount Raised
- $10M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $10M
- Latest Funding Round
- Series A
Company Momentum
PositiveFreya Biosciences LinkedIn following is increasing, signaling rising market interest, while its workforce is growing, indicating business expansion.
Employee Trend
Freya Biosciences had 27 employees as of November 16, 2026. The number of employees increased by 0 (0.00%) week-over-week.
Social Trend
Freya Biosciences had 5,323 followers as of November 16, 2026. The number of followers increased by 39 (0.74%) week-over-week.
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Aug 14, 2025 | Series A | $10.40M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| Bill & Melinda Gates Foundation | Series A |
| Export and Investment Fund of Denmark | Series A |
Similar Companies
A snapshot of private companies similar to Freya Biosciences, helping you discover and navigate related company profiles.








